docetaxel anhydrous has been researched along with Back Pain in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, Y; Hatakeyama, S; Imai, A; Iwamura, H; Koie, T; Ohyama, C; Tanaka, T; Tanaka, Y; Tokui, N; Yamamoto, H; Yoneyama, T; Yoshikawa, K | 1 |
Bias, P; Bondarenko, IM; Buchner, A | 1 |
Burdick, RK; Cunningham, SC; Cusnir, M; Moesinger, R; Van Echo, DA | 1 |
Albain, KS; Clark, JI; Fisher, S; Hantel, A; Kancharla, K; Millbrandt, L; Panganiban, J; Qamar, R | 1 |
2 trial(s) available for docetaxel anhydrous and Back Pain
Article | Year |
---|---|
Incidence of bone pain in patients with breast cancer treated with lipegfilgrastim or pegfilgrastim: an integrated analysis from phase II and III studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Back Pain; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Double-Blind Method; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Male; Middle Aged; Musculoskeletal Pain; Myalgia; Polyethylene Glycols; Recombinant Proteins; Taxoids | 2016 |
Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Survival Analysis; Taxoids; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
2 other study(ies) available for docetaxel anhydrous and Back Pain
Article | Year |
---|---|
A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Biopsy, Needle; Bone Neoplasms; Diagnostic Imaging; Disseminated Intravascular Coagulation; Docetaxel; Drug Resistance, Neoplasm; False Negative Reactions; Fatal Outcome; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Unknown Primary; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Transurethral Resection of Prostate | 2014 |
Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Female; Fluorouracil; Gemcitabine; Humans; Liver Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Pancreatectomy; Pancreatic Neoplasms; Splenectomy; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2003 |